Completed PHASE3 INTERVENTIONAL 2-arm NCT00621790

Fenoldopam and Acute Renal Failure (FENO HSR)

Efficacy of Fenoldopam in Reducing the Need for Renal Replacement Therapy After Cardiac Surgery. A Randomized Controlled Study.

Sponsor: Università Vita-Salute San Raffaele

Conditions Acute Renal Failure

Interventions fenoldopam placebo

Updated 7 times since 2017 Last updated: Oct 13, 2015 Started: Feb 29, 2008 Primary completion: Jun 30, 2013 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Acute Renal Failure, this trial is completed. The trial is conducted by Università Vita-Salute San Raffaele and has accumulated 7 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE3
Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Università Vita-Salute San Raffaele

Data source: Università Vita-Salute San Raffaele

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bologna, Italy , Brescia, Italy , Catanzaro, Italy , Florence, Italy , Lecce, Italy , Lugo Di Ravenna, Italy , Messina, Italy , Milan, Italy , Napoli, Italy , Padua, Italy and 8 more locations